Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
113.58
-0.81 (-0.71%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,034,863
Open
113.66
Bid (Size)
112.55 (1)
Ask (Size)
113.90 (1)
Prev. Close
114.39
Today's Range
111.51 - 113.93
52wk Range
99.14 - 134.63
Shares Outstanding
2,531,374,696
Dividend Yield
2.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
In-Depth Analysis: Merck & Co Versus Competitors In Pharmaceuticals Industry
Today 11:00 EDT
Via
Benzinga
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
Today 6:15 EDT
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Via
InvestorPlace
Performance
YTD
+0.30%
+0.30%
1 Month
-11.35%
-11.35%
3 Month
-11.72%
-11.72%
6 Month
-9.45%
-9.45%
1 Year
+4.29%
+4.29%
More News
Read More
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
August 09, 2024
Via
Benzinga
'I'm Not Proud Of Myself': Jim Cramer Says He Bought 'Worst Of The Three' GE Stocks
August 09, 2024
Via
Benzinga
Uncovering Dividend Opportunities with NYSE:MRK.
August 09, 2024
Via
Chartmill
Looking Into Merck & Co's Recent Short Interest
August 08, 2024
Via
Benzinga
Behind the Scenes of Merck & Co's Latest Options Trends
August 05, 2024
Via
Benzinga
Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
August 09, 2024
From
Merck & Co., Inc.
Via
Business Wire
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Reports on ‘Synergistic Effect’ of Lead Compound Plus GLP-1 in AD Treatment Model
August 08, 2024
Via
Investor Brand Network
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
August 08, 2024
Via
Benzinga
Merck Provides Update on Phase 3 KeyVibe-008 Trial Evaluating an Investigational Fixed-Dose Combination of Vibostolimab and Pembrolizumab in Patients With Extensive-Stage Small Cell Lung Cancer
August 08, 2024
From
Merck & Co., Inc.
Via
Business Wire
The 3 Best Biotech Stocks to Buy in August 2024
August 08, 2024
Via
InvestorPlace
NYSE:MRK is an undervalued gem with solid fundamentals.
August 07, 2024
Via
Chartmill
Palantir’s AI Evolution: Strategic Shift Or Marketing Ploy?
August 06, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Alzheimer’s Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
August 06, 2024
Via
FinancialNewsMedia
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
August 06, 2024
From
FN Media Group LLC
Via
GlobeNewswire
2 Dividend Stocks to Buy and Never Sell
August 06, 2024
Via
The Motley Fool
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070
August 06, 2024
From
Daiichi Sankyo
Via
Business Wire
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Via
The Motley Fool
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
August 05, 2024
Via
Benzinga
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Via
Benzinga
Merck's Blockbuster Vaccine Gardasil Sales In China: Analyst Highlights Challenges and Opportunities
August 05, 2024
Via
Benzinga
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
August 05, 2024
Via
Investor's Business Daily
Is It Time to Buy July's Worst-Performing Dow Jones Stocks?
August 05, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.